Product Wiki · Recalls · EU Safety Gate (RAPEX)

Super Glue — recall SR/03000/25

EU Safety Gate (RAPEX) · Lithuania · 2025-08-15 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/03000/25
Date of alert
2025-08-15
Country / jurisdiction
Lithuania
Risk level
Serious risk
Risk type
Chemical
Brand
Shenqiang
Product category
Chemical products
Product type
Glue
Barcode (EAN/GTIN)
6976034465310
Reported risk: Produkte yra chloroformo (išmatuota vertė 30,66 % masės). Chloroformas dirgina odą, gali pakenkti sveikatai įkvėpus arba prarijus ir įtariama, kad sukelia vėžį. Produktas neatitinka REACH reglamento reikalavimų.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Withdrawal of the product from the market
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Super Glue

Risk Description (original English): The product contains chloroform (measured value 30.66 % by weight). Chloroform causes skin irritation, can be harmful to health if inhaled or swallowed and is suspected to cause cancer.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10095632

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.